Uterine fibroids are a common cause of heavy uterine bleeding and pain in reproductive-age women and the most prevalent benign gynecologic tumor. They are responsible for almost half of all hysterectomies performed annually in the United States. Traditionally, surgeons have treated fibroids through removal by open abdominal surgery – either by hysterectomy, in which the entire uterus is removed, or by myomectomy, where the uterus remains and only the fibroids are removed.
St. Luke’s offers a multidisciplinary approach to provide the latest and most advanced treatment options for uterine fibroids, including minimally invasive surgical techniques and non-invasive radiologic procedures. MINIMALLY INVASIVE SURGERY CHI St. Luke’s Health's highly experienced affiliated gynecologists are skilled surgeons who employ both open-incision surgical procedures as well as newer, more sophisticated laparoscopic and hysteroscopic.
In fact, CHI St. Luke’s Health - Sugar Land Hospital is a recognized leader in such minimally invasive surgical alternatives for removal of uterine fibroids. These alternatives allow a woman to leave the hospital the same day of surgery and return to normal activities almost immediately.
UTERINE FIBROID EMBOLIZATION (UFE) Uterine Fibroid Embolization (UFE) is a non-surgical and less invasive method for treating symptomatic fibroid tumors through interventional radiology.
Also known as uterine artery embolization, or UAE, this procedure cuts off the blood supply to the fibroids and has been performed safely and successfully in thousands of women worldwide since the 1990s. Compared to traditional fibroid surgery, UFE requires no general anesthesia, is less invasive with no surgical scars, and allows a quicker return to normal activities. Also, there is no evidence that fibroids will return.